Preclinical Evaluation of Fenbendazole for Controlling <i>Gyrodactylus kobayashii</i> (Monogenea, Gyrodactylidae) in Goldfish: Dose Optimization and Safety Assessment.

Animals (Basel) · 2025 · PMC12189257 · PMID 40564366

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

an increasing trendp < 0.05actually significant

SOD activity in the liver also exhibited an increasing trend after fenbendazole administration, peaking around 6 days post-treatment, significantly higher than the control group ( p < 0.05).

also in 38,133 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Preclinical Evaluation of Fenbendazole for Controlling &lt;i&gt;Gyrodactylus kobayashii&lt;/i&gt; (Monogenea, Gyrodactylidae) in Goldfish: Dose Optimization and Safety Assessment.

The sentences

Preclinical Evaluation of Fenbendazole for Controlling <i>Gyrodactylus kobayashii</i> (Monogenea, Gyrodactylidae) in Goldfish: Dose Optimization and Safety Assessment.